Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.4944
+0.1100 (28.62%)
At close: Jan 9, 2026, 4:00 PM EST
0.4991
+0.0047 (0.95%)
After-hours: Jan 9, 2026, 7:59 PM EST
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $78.67 million as of January 9, 2026. Its market cap has decreased by -85.02% in one year.
Market Cap
78.67M
Enterprise Value
30.37M
1-Year Change
-85.02%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $78.67M, a decrease of -36.98%. That is a compound annual growth rate of -6.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 78.67M | 18.65% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |